Literature DB >> 28110888

Cerebral Salt Wasting Is the Most Common Cause of Hyponatremia in Stroke.

Jayantee Kalita1, Rajesh Kumar Singh1, Usha Kant Misra2.   

Abstract

OBJECTIVE: The study aimed to evaluate the frequency, severity, and causes of hyponatremia in stroke and its influence on outcome.
MATERIALS AND METHODS: Consecutive computed tomography- or magnetic resonance imaging-proven stroke patients within 7 days of stroke were included. Severity of stroke was assessed using the National Institute of Health Stroke Scale and consciousness using the Glasgow Coma Scale. Hyponatremia was defined if 2 consecutive serum sodium levels were <135 mEq/L and hypernatremia if >145 mEq/L. Causes of hyponatremia, such as cerebral salt wasting (CSW) and syndrome of inappropriate secretion of antidiuretic hormone (SIADH), were based on predefined criteria. Patients with CSW were managed by salt supplementation and normal saline, and fludrocortisone was used in refractory cases. In SIADH, fluid was restricted. Outcome on discharge was defined using the modified Rankin Scale (mRS).
RESULTS: One hundred patients with stroke were included: 47% had ischemic stroke and 53% had intracerebral hemorrhage. Forty-three percent of the patients had hyponatremia, 6% had hypernatremia, and 4% had both. Hyponatremia was due to CSW in 19 (44.2%), SIADH in 3 (7%), miscellaneous causes in 14 (32.6%), and indeterminate in 7 (16.3%) patients. Duration of hospitalization was the independent predictor of hyponatremia and CSW. Fourteen patients died, whereas 15 had good outcome (mRS score of ≤2) and 71 had poor outcome (mRS score of 3-5). Hypernatremia was associated with high mortality compared with eunatremia and hyponatremia.
CONCLUSION: Hyponatremia occurred in 43% of stroke patients. CSW was the most common cause of hyponatremia. Hyponatremia, however, was not related to death or disability.
Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glasgow Coma Scale; Stroke; cerebral salt wasting; hyponatremia; syndrome of inappropriate secretion of antidiuretic hormone; systemic inflammatory response syndrome

Mesh:

Substances:

Year:  2017        PMID: 28110888     DOI: 10.1016/j.jstrokecerebrovasdis.2016.12.011

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

Review 1.  Differential diagnosis between syndrome of inappropriate antidiuretic hormone secretion and cerebral/renal salt wasting syndrome in children over 1 year: proposal for a simple algorithm.

Authors:  Flaminia Bardanzellu; Maria Antonietta Marcialis; Roberta Frassetto; Alice Melis; Vassilios Fanos
Journal:  Pediatr Nephrol       Date:  2021-09-01       Impact factor: 3.651

2.  Safety and Efficacy of Fludrocortisone in the Treatment of Cerebral Salt Wasting in Patients With Tuberculous Meningitis: A Randomized Clinical Trial.

Authors:  Usha K Misra; Jayantee Kalita; Mritunjai Kumar
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

Review 3.  Complementary examinations other than neuroimaging and neurosonology in acute stroke.

Authors:  Adrià Arboix; Víctor Obach; Maria José Sánchez; Joan Massons
Journal:  World J Clin Cases       Date:  2017-06-16       Impact factor: 1.337

4.  Malignant middle cerebral artery infarction following subacute subdural hematoma: A case report and literature review.

Authors:  Saad Moughal; Micaela Uberti; Alaa Al-Mousa; Salem Al-Dwairy; Anan Shtaya; Erlick Pereira
Journal:  Surg Neurol Int       Date:  2021-03-17

Review 5.  Inappropriate Antidiuretic Hormone Secretion and Cerebral Salt-Wasting Syndromes in Neurological Patients.

Authors:  Haiying Cui; Guangyu He; Shuo Yang; You Lv; Zongmiao Jiang; Xiaokun Gang; Guixia Wang
Journal:  Front Neurosci       Date:  2019-11-08       Impact factor: 4.677

Review 6.  Mechanism, spectrum, consequences and management of hyponatremia in tuberculous meningitis.

Authors:  Usha K Misra; Jayantee Kalita
Journal:  Wellcome Open Res       Date:  2021-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.